Xtant Medical Holdings (XTNT) Gross Profit (2010 - 2025)

Xtant Medical Holdings (XTNT) has 16 years of Gross Profit data on file, last reported at $17.8 million in Q4 2025.

• On a quarterly basis, Gross Profit rose 10.8% year-over-year to $17.8 million in Q4 2025; TTM through Dec 2025 was $84.3 million, a 23.54% increase from a year earlier, with the FY2025 full-year figure at $84.3 million, up 23.54% from the prior year.
• Gross Profit for Q4 2025 stood at $17.8 million, down from $22.0 million in the prior quarter.
• Over the last five years, Gross Profit for XTNT reached as high as $24.3 million in Q2 2025 and fell as low as $7.2 million in Q3 2021.
• Historically, Gross Profit has averaged $13.6 million across 5 years, with a median of $13.9 million in 2023.
• Across the five-year window, Gross Profit decreased 22.24% in 2021 and jumped 106.32% in 2023, its largest moves.
• Year by year, Gross Profit stood at $7.7 million in 2021, then advanced by 7.94% to $8.3 million in 2022, then soared by 106.32% to $17.1 million in 2023, then retreated by 6.49% to $16.0 million in 2024, then rose by 10.8% to $17.8 million in 2025.
• Per Business Quant data, the three most recent Gross Profit figures were $17.8 million in Q4 2025, $22.0 million in Q3 2025, and $24.3 million in Q2 2025.